ALKS

Alkermes Stock Price

18.82
0.36 (1.95%)
Upgrade to Real-Time
Afterhours (Closed)
18.82
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Alkermes Plc ALKS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.36 1.95% 18.82 17:15:00
Open Price Low Price High Price Close Price Previous Close
18.37 18.33 18.86 18.82 18.46
Bid Price Ask Price Spread News
18.26 18.97 0.71 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,987 763,279 $ 18.64 $ 14,223,921 1,172,528 11.98 - 21.9799
Last Trade Time Type Quantity Stock Price Currency
16:05:39 average 1,747 $ 18.82 USD

Alkermes Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.00B 159.15M 111.83M $ 1.17B $ -73.54M -1.26 -39.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 2.17k 1.30%

more financials information »

Alkermes News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALKS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week18.3618.8618.0718.39605,7170.462.51%
1 Month16.2519.3016.0017.901,143,4852.5715.82%
3 Months16.4019.6815.3517.231,207,8762.4214.76%
6 Months16.6121.4515.3517.881,263,0052.2113.31%
1 Year20.9921.979911.9817.581,470,592-2.17-10.34%
3 Years54.0471.2211.9827.671,189,617-35.22-65.17%
5 Years72.9180.7111.9835.231,102,861-54.09-74.19%

Alkermes Description

Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.


Your Recent History
NASDAQ
ALKS
Alkermes
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.